TY - JOUR
T1 - Increased interleukin 5 production in eosinophilic Sézary syndrome
T2 - Regulation by interferon alfa and interleukin 12
AU - Suchin, Karen Rebecca
AU - Cassin, Maureen
AU - Gottleib, Scott L.
AU - Sood, Shobana
AU - Cucchiara, Andrew J.
AU - Vonderheid, Eric C.
AU - Rook, Alain H.
PY - 2001
Y1 - 2001
N2 - Background: Peripheral eosinophilia occurs in a small subpopulation of patients with cutaneous T-cell lymphoma (CTCL) and denotes a poor prognosis. Clinical studies have suggested that the Sézary cell is a T H2 type helper T cell that produces cytokines that enhance the differentiation and activation of eosinophils. Interferon alfa (IFN-α) and interleukin 12 are effective therapeutic agents for CTCL and other hematologic disorders. Objective: Our purpose was to determine the inhibitory activity of IFN-α and IL-12 on IL-5 production in vitro by peripheral blood mononuclear cells (PBMCs) obtained from patients with CTCL and eosinophilia. Methods: Suppression of IL-5 production by IFN-α and IL-12 was assessed by comparing IL-5 production by PBMCs from patients with Sézary syndrome and eosinophilia when cultured alone or in the presence of either IFN-α or IL-12. Results: A marked increase in IL-5 production by PBMCs from patients with Sézary syndrome and eosinophilia was observed. IL-5 production was markedly reduced when PBMCs were exposed to IFN-α or IL-12. Conclusion: These results suggest that IFN-α and perhaps IL-12 may produce a therapeutic response in patients with CTCL and eosinophilia through direct suppression of II.-5 production by malignant Sézary cells.
AB - Background: Peripheral eosinophilia occurs in a small subpopulation of patients with cutaneous T-cell lymphoma (CTCL) and denotes a poor prognosis. Clinical studies have suggested that the Sézary cell is a T H2 type helper T cell that produces cytokines that enhance the differentiation and activation of eosinophils. Interferon alfa (IFN-α) and interleukin 12 are effective therapeutic agents for CTCL and other hematologic disorders. Objective: Our purpose was to determine the inhibitory activity of IFN-α and IL-12 on IL-5 production in vitro by peripheral blood mononuclear cells (PBMCs) obtained from patients with CTCL and eosinophilia. Methods: Suppression of IL-5 production by IFN-α and IL-12 was assessed by comparing IL-5 production by PBMCs from patients with Sézary syndrome and eosinophilia when cultured alone or in the presence of either IFN-α or IL-12. Results: A marked increase in IL-5 production by PBMCs from patients with Sézary syndrome and eosinophilia was observed. IL-5 production was markedly reduced when PBMCs were exposed to IFN-α or IL-12. Conclusion: These results suggest that IFN-α and perhaps IL-12 may produce a therapeutic response in patients with CTCL and eosinophilia through direct suppression of II.-5 production by malignant Sézary cells.
UR - http://www.scopus.com/inward/record.url?scp=0035136010&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035136010&partnerID=8YFLogxK
U2 - 10.1067/mjd.2001.109853
DO - 10.1067/mjd.2001.109853
M3 - Article
C2 - 11148473
AN - SCOPUS:0035136010
SN - 0190-9622
VL - 44
SP - 28
EP - 32
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 1
ER -